• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Eruptive keratoacanthomas secondary to nivolumab immunotherapy.

作者信息

Bednarek Robert, Marks Katherine, Lin George

机构信息

Department of Dermatology, Geisinger Medical Center, Danville, PA, USA.

Department of Pathology, Division of Dermatopathology, Geisinger Medical Center, Danville, PA, USA.

出版信息

Int J Dermatol. 2018 Mar;57(3):e28-e29. doi: 10.1111/ijd.13893. Epub 2018 Jan 10.

DOI:10.1111/ijd.13893
PMID:29318617
Abstract
摘要

相似文献

1
Eruptive keratoacanthomas secondary to nivolumab immunotherapy.纳武单抗免疫治疗继发的爆发性角化棘皮瘤
Int J Dermatol. 2018 Mar;57(3):e28-e29. doi: 10.1111/ijd.13893. Epub 2018 Jan 10.
2
Eruptive keratoacanthomas arising in the setting of lichenoid toxicity after programmed cell death 1 inhibition with nivolumab.在使用纳武单抗抑制程序性细胞死亡1后出现苔藓样毒性背景下发生的爆发性角化棘皮瘤。
J Eur Acad Dermatol Venereol. 2018 Feb;32(2):e58-e59. doi: 10.1111/jdv.14503. Epub 2017 Aug 29.
3
Eruptive keratoacanthoma with spontaneous regression arising from a cervical squamous cell carcinoma patient treated with nivolumab.一名接受纳武单抗治疗的宫颈鳞状细胞癌患者出现自发消退的爆发性角化棘皮瘤。
J Dermatol. 2019 May;46(5):e177-e178. doi: 10.1111/1346-8138.14684. Epub 2018 Oct 24.
4
Treatment of PD-1/PD-L1 Inhibitor-Induced Dermatitis Resolves Concomitant Eruptive Keratoacanthomas.PD-1/PD-L1抑制剂诱导性皮炎的治疗可使伴发的爆发性角化棘皮瘤消退。
JAMA Dermatol. 2020 May 1;156(5):598-600. doi: 10.1001/jamadermatol.2020.0176.
5
Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy.纳入纳武利尤单抗扩展使用项目（EAP）的意大利转移性肾细胞癌老年患者的疗效和安全性数据。
PLoS One. 2018 Jul 6;13(7):e0199642. doi: 10.1371/journal.pone.0199642. eCollection 2018.
6
A Psoriasiform Drug Eruption Secondary to Nivolumab for Hepatocellular Carcinoma: A Case Report.一例因纳武单抗治疗肝细胞癌继发的银屑病样药疹：病例报告
Hepatology. 2019 Oct;70(4):1477-1479. doi: 10.1002/hep.30659. Epub 2019 May 20.
7
Immunotherapy in Dialysis-Dependent Cancer Patients: Our Experience in Patients With Metastatic Renal Cell Carcinoma and a Review of the Literature.透析依赖型癌症患者的免疫治疗：我们对转移性肾细胞癌患者的经验及文献综述。
Clin Genitourin Cancer. 2019 Oct;17(5):e903-e908. doi: 10.1016/j.clgc.2019.06.009. Epub 2019 Jul 8.
8
[A Case of Rheumatoid Arthritis Developed during Treatment with Nivolumab for Renal Cell Carcinoma].[1例在使用纳武单抗治疗肾细胞癌期间发生的类风湿关节炎]
Hinyokika Kiyo. 2018 Oct;64(10):397-401. doi: 10.14989/ActaUrolJap_64_10_397.
9
[A Case of Nivolumab-Induced Isolated Adrenocorticotropic Hormone Deficiency Presenting Dyspnea].[一例因纳武单抗诱发孤立性促肾上腺皮质激素缺乏症并出现呼吸困难的病例]
Hinyokika Kiyo. 2018 Oct;64(10):391-395. doi: 10.14989/ActaUrolJap_64_10_391.
10
Two cases of anti-programmed cell death 1-associated bullous pemphigoid-like disease and eruptive keratoacanthomas featuring combined histopathology.两例抗程序性细胞死亡1相关的大疱性类天疱疮样疾病及具有联合组织病理学特征的爆发性角化棘皮瘤
J Eur Acad Dermatol Venereol. 2017 Aug;31(8):e378-e380. doi: 10.1111/jdv.14179. Epub 2017 Mar 13.

引用本文的文献

1
Case Report: Immune-related eruptive keratoacanthoma with fungal coinfection under PD-1 inhibitor therapy: a diagnostic and therapeutic challenge.病例报告：PD-1抑制剂治疗下伴有真菌合并感染的免疫相关爆发性角化棘皮瘤：诊断和治疗挑战
Front Pharmacol. 2025 Aug 13;16:1619450. doi: 10.3389/fphar.2025.1619450. eCollection 2025.
2
Eruptive keratoacanthoma secondary to immune checkpoint inhibitors: a narrative review.免疫检查点抑制剂继发的爆发性角化棘皮瘤：一项叙述性综述
Arch Dermatol Res. 2025 Jan 13;317(1):234. doi: 10.1007/s00403-024-03694-7.
3
Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm.
与遗传综合征相关的多发性角化棘皮瘤：叙述性综述及诊断算法建议
Am J Clin Dermatol. 2025 Jan;26(1):45-59. doi: 10.1007/s40257-024-00900-0. Epub 2024 Nov 21.
4
To treat or not to treat: PD-L1 inhibitor-induced keratoacanthoma and squamous cell carcinoma.治疗还是不治疗：程序性死亡受体1配体（PD-L1）抑制剂诱发的角化棘皮瘤和鳞状细胞癌
Arch Dermatol Res. 2023 May;315(4):903-915. doi: 10.1007/s00403-022-02468-3. Epub 2022 Nov 17.
5
Hyperkeratotic Skin Adverse Events Induced by Anticancer Treatments: A Comprehensive Review.抗肿瘤治疗引起的角化过度性皮肤不良反应：全面综述。
Drug Saf. 2020 May;43(5):395-408. doi: 10.1007/s40264-020-00907-6.
6
Transient eruptive keratoacanthomas associated with nivolumab.与纳武单抗相关的短暂性爆发性角化棘皮瘤
JAAD Case Rep. 2019 Apr 5;5(4):342-345. doi: 10.1016/j.jdcr.2019.01.025. eCollection 2019 Apr.